 |
|
Real-World Outcomes of Amikacin Liposome Inhalation Suspension for Refractory Mycobacterium avium Complex Pulmonary Disease
Bo-Guen Kim, Sae Rom Kim, Byung Woo Jhun
Tuberc Respir Dis. 2024;87(2):202-205. Published online 2023 Sep 20 DOI: https://doi.org/10.4046/trd.2023.0120
|
|
Citations to this article as recorded by
 Acquisition of Amikacin Resistance during Amikacin Liposome Inhalation Suspension Add-on Therapy for Mycobacterium avium Complex Pulmonary Disease
Hirohito Sano, Naoya Fujino, Tadahisa Numakura, Mitsuhiro Yamada, Naoki Tode, Hisatoshi Sugiura
Annals of the American Thoracic Society.2024; 21(3): 526. CrossRef Amikacin Liposome Inhalation Suspension in the Real-World Management of Refractory Mycobacterium avium Complex Pulmonary Disease
Toyoshi Yanagihara, Hiroaki Ogata, Asami Mori, Masako Kadowaki, Yuki Moriuchi, Akiko Ishimatsu, Junji Otsuka, Kazuhito Taguchi, Atushi Moriwaki, Makoto Yoshida
Cureus.2024;[Epub] CrossRef
|